GENEVA, Sept. 24 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2026/084402) for “COMPOUND HAVING ANTI-CANCER ACTIVITY, AND ANTIBODY CONJUGATE DRUG THEREOF”. With publication no. WO/2026/194963, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....